However, while several NSAIDs repress transcription factors of the NF-κB family, which can be a driver of tumorigenesis in hematopoietic and solid tumor cells, indomethacin does not inactivate NF-κB, AP1, and cancer-relevant kinases. Here, NFKB1 is linked to cancer.